| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |